Flutiform K-haler 50 microgram /5 microgram, 125 microgram /5 microgram per actuation pressurised inhalation, suspension. *
Company:
Mundipharma Pharmaceuticals Limited - Formerly Napp LaboratoriesStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 29 July 2019
File name
pil_1564404735.pdf
Reasons for updating
- Correction of spelling/typing errors
Updated on 29 July 2019
File name
spc_1564404612.pdf
Reasons for updating
- Addition of joint SPC covering all presentations
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 27 September 2018
File name
ie-SPC-cleanflutiformkhaler125_5pisen_for_medicines_ie_1538060780.pdf
Reasons for updating
- New individual SPC (was previously included in combined SPC)
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
New individual SmPC
Updated on 09 August 2018
File name
ie-PIL-cleanflutiformkhaler50_5_125_5pisen_for_medicines_ie_1533809818.pdf
Reasons for updating
- New PIL for new product
Updated on 09 August 2018
File name
Combined_SPC-clean_flutiformkhaler50_5_and_125_5_for_medicines_ie_1533809749.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
New SPC for new product